CrossrefInfokarte
Early Treatment Failure in Real-World Bispecific-Antibody Therapy for Relapsed or Refractory Multiple Myeloma: Pathways, Determinants, and Measurement Gaps
OncoTargets and Therapy · 2026-11 · Volume 19 · 1-18
DOI: 10.2147/ott.s653346 ↗Abstract
Kein Abstract verfügbar.
EUVIMED